Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Diethyl-[6-(4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl)-naphthalen-2-yl-methyl]-ammonium chloride for use in the treatment of muscular dystrophy

Diethyl-[6-(4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl)-naphthalen-2-yl-methyl]-ammonium chloride for use in the treatment of muscular dystrophy

US Patent 9867799 · Granted Jan 16, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Physically and chemically stable oral suspensions of givinostat2020
Benzo-N-hydroxy amide compounds having antitumor activity2020
Use of histone deacetylase inhibitors for the care of philadelphia-negative myel2016
Diethyl-[6-(4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl)-naphthalen-2-yl-methy2016
Diethyl-[6-(4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl)-naphthalen-2-yl-methy2016
Diethyl-[6-(4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl)-naphthalen-2-yl-methy2016
Diethyl-[6-(4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl)-naphthalen-2-yl-methy2016
Non-selective somatostatin analogues2015
Riluzole aqueous suspensions2014
Derivatives of N-hydroxybenzamide for treating HIV infections2014
Use of hydroxamic acid derivatives for the preparation of anti-tumour medicament2012
Method for treating Philadelphia-negative myeloproliferative syndromes2012